Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Dementia

Hormone replacement therapy does not alter cognition, study suggests

Study measured the effects of hormone replacement therapy on cognition and mood in healthy women.

Source: © Dmitriy Shironosov Dreamstime.com

Women who used HRT based on oral conjugated equine oestrogens had reduced levels of tension, anxiety and depression

The use of hormone replacement therapy (HRT) in recently post-menopausal women does not improve cognition, but may improve mood, results from a recent US study indicate.

Millions of women use HRT to mitigate the uncomfortable symptoms of menopause, including hot flushes and a lack of acuity, despite debate about its benefits and risks since the launch of the first HRT, Premarin, in 1942. One concern about HRT is that it may increase the likelihood of dementia and Alzheimer’s disease. The Cognitive and Affective Study, a subset of the Kronos Early Estrogen Prevention Study (KEEPS), set out to measure the impact.

While the key focus of the KEEPS study was the cardiovascular impact of HRT in early menopause, the KEEPS-Cog subset concentrated on mood and cognition. In KEEPS-Cog, 431 recently postmenopausal women (mean age 52.6 years) received HRT (oral oestrogen pills and progesterone, or transdermal oestradiol patches and progesterone), with 262 getting placebo pills and patches.

The results, published in PLoS Medicine[1] on 2 June 2015, showed that HRT did not worsen cognitive performance over the four years measured by the Modified Mini-Mental State (3MS), an expanded version of the widely used Mini-Mental State Examination (MMSE). This supports the results of the Women’s Health Initiative Memory Study of Younger Women (WHIMSY) that was published in 2013[2].

“There has been a lot of focus on the harm of [HRT], so showing that there isn’t an increase in cognitive adverse events can be seen as reassuring,” says Haitham Hamoda, clinical lead of the menopause service at King’s College London, and member of the medical advisory council at the British Menopause Society.

At the same time, the oestrogen treatment did not improve cognitive outcomes, as some researchers had hoped. This may be because the subjects were healthy women in their early fifties or because of measures used. Anthony Mander, consultant gynaecologist at the Nuffield Manor Hospital, Oxford suggests the latter. He believes that the MMSE test is too crude, and therefore the use of MMSE-based measures could miss significant differences. He suggests the use of more sensitive computerised cognitive testing.

The study results included more positive results for the impact of HRT on mood. Treatment based on oral conjugated equine oestrogens (with or without progesterone) significantly reduced levels of tension, anxiety and depression, which can be debilitating symptoms for women undergoing menopause.

The researchers suggest that decisions about HRT should be made by a woman and her doctor, weighing the benefits and risks.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20068733

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Lecture Notes in Pharmacy Practice

    Lecture Notes in Pharmacy Practice

    A comprehensive study guide which summarises the basic principles in pharmacy practice. Clear, bulleted information for quick reference.

    £43.00Buy now
  • MCQs in Pharmacy Practice

    MCQs in Pharmacy Practice

    A study aid with 800 MCQs. Assess your knowledge, analytical skills, and ability to apply this knowledge base in clinical practice.

    £25.00Buy now
  • Basic Pharmacokinetics

    Basic Pharmacokinetics

    A clear and concise basic pharmacokinetics textbook. Shows how to apply the principles to achieve successful drug therapy.

    £54.00Buy now
  • FASTtrack: Pharmacology

    FASTtrack: Pharmacology

    FASTtrack: Pharmacology is a study guide providing an account of drug action, as well as dealing with molecular pharmacology at a more advanced level.

    £28.00Buy now
  • Drugs in Use

    Drugs in Use

    Optimise drug therapy for your patients. These case studies help you bridge the gap between theoretical medicines knowledge and practical applications.

    £43.00Buy now
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.